(Q39202093)

English

Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma

scientific article published on 28 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Epstein–Barr virus

0 references

membrane protein

1 reference

based on heuristic

inferred from title

author name string

Joo Hyun Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Won Seog Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Chaehwa Park

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

28 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

2035-2040

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

The Epstein-Barr virus and its association with human cancers

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

SNARK, a novel downstream molecule of EBV latent membrane protein 1, is associated with resistance to cancer cell death

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Activation-induced deaminase: light and dark sides

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

AID in somatic hypermutation and class switch recombination

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

A coming-of-age story: activation-induced cytidine deaminase turns 10.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

AID expression during B-cell development: searching for answers.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

RASSF6 is a novel member of the RASSF family of tumor suppressors

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

The balance between Pax5 and Id2 activities is the key to AID gene expression

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Identification of a ubiquitously active promoter of the murine activation-induced cytidine deaminase (AICDA) gene

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Tumor progression: the effects of thrombospondin-1 and -2.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

DIO-1 is a gene involved in onset of apoptosis in vitro, whose misexpression disrupts limb development

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Expression of BIRC7 protein and mRNA in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoter

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.769218

21 January 2018

Identifiers

10.3109/10428194.2013.769218

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

release_27h4x5vcxfcabkfjb7kc7b5vbm

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39202093&oldid=1812823603"